The Hypertension in the Very Elderly Trial (HYVET), a randomized trial with hip fracture as a secondary outcome measure, revealed that treatment with a thiazide-like diuretic ± ACE inhibitor may reduce the risk of hip fracture [31]. The gene discussed is ACE; the disease is Hypertension.